Q192-193: Disease Status at the Last Evaluation Prior to the Start of the Preparative Regimen / Infusion
Question 192: What was the disease status at the last evaluation prior to the start of the preparative regimen?
Indicate the disease status using the international working group criteria provided in CLL Response Criteria section of the Forms Instructions Manual. The pre-HCT disease status is determined by a disease assessment, such as hematologic testing, pathology study, and/or physician assessment.
If no chemotherapy was given within 6 months of the start of the preparative regimen, report “Untreated.”
If the best response to the line of therapy was not evaluated, report “not assessed (NA)” and skip question 193.
If the best response to the line of therapy is unknown, report “unknown” and skip question 193.
Question 193: Date of the most recent assessment for disease status prior to the preparative regimen
Enter the date of the most recent assessment of disease status prior to the start of the preparative regimen. Report the date of the pathologic evaluation (e.g., bone marrow biopsy), radiographic examination (e.g., X-rays, CT scans, MRI scans, PET scans), or blood/serum assessment (e.g., CBC, peripheral blood smear). Enter the date the sample was collected for pathologic and laboratory evaluations; enter the date the imaging took place for radiographic assessments. If no pathologic, radiographic, or laboratory assessment was performed within the pre-transplant work-up time period, report the most recent office visit in which the physician assessed the recipient’s disease status.
If the exact date is not known, use the process described for reporting partial or unknown dates in General Instructions, General Guidelines for Completing Forms.
Need more help with this?
Don’t hesitate to contact us here.